Ryuichi Mizuno

9PUBLICATIONS
16CO-AUTHORS
Neurology and neuromuscular diseasesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 17, 2026
A Nationwide Descriptive Analysis of Real-World Outcomes After Radical Prostatectomy in Japan Using the National Clinical Database.

|Feb 06, 2024
Prevalence and management of proteinuria associated with vascular endothelial growth factor receptor-targeted tyrosine kinase inhibitor treatment in advanced renal cell carcinoma, hepatocellular carcinoma, and thyroid cancer.

Taigo Kato, Ryuichi Mizuno, Hideaki Miyake

|Aug 17, 2023
Pre-existing Interstitial Lung Abnormalities and Immune Checkpoint Inhibitor-Related Pneumonitis in Solid Tumors: A Retrospective Analysis.

Kohei Horiuchi, Shinnosuke Ikemura, Takashi Sato

|Feb 02, 2022
Potential therapeutic effects of adjuvant chemotherapy after neoadjuvant chemotherapy for locally advanced muscle-invasive bladder cancer.

Minami Omura, Eiji Kikuchi, Keisuke Shigeta

|Jun 08, 2021
On-treatment C-reactive protein control could predict response to subsequent anti-PD-1 treatment in metastatic renal cell carcinoma.

Kimiharu Takamatsu, Ryuichi Mizuno, Yuto Baba

|Feb 16, 2021
Site-specific differences in survival among upper and lower tract urothelial carcinoma patients treated with radical surgery.

Tadatsugu Anno, Eiji Kikuchi, Keisuke Shigeta

Pageof 2

Frequent Collaborators

1 joint publications

Shuji Mikami

1 joint publications

Kimiharu Takamatsu

1 joint publications

Kyohei Hakozaki

1 joint publications

Kohei Horiuchi